Overview of Colorectal Cancer Genetics

Surgical Oncology Clinics of North America

Volumn 18, Issue 4, 2009, Pages 573-583

  Gryfe, Robert ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Chromosomal instability; Colorectal cancer genetics; CpG island methylation; Microsatellite instability; Oncogenes; Tumor suppressor genes

Indexed keywords

APC PROTEIN; AURORA A KINASE; B RAF KINASE; BCR ABL PROTEIN; BETA CATENIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; K RAS PROTEIN; MISMATCH REPAIR PROTEIN PMS2; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; PROTEIN MAD2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; PROTEIN P53; SMAD4 PROTEIN; WNT PROTEIN;

CANCER GENETICS; CANCER GROWTH; CANCER INVASION; CLONAL VARIATION; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; GENE INACTIVATION; GENE MUTATION; GENETIC MODEL; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MICROSATELLITE INSTABILITY; ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; HUMANS; MUTATION; NEOPLASM PROTEINS;

EID: 70349303454     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2009.08.004     Document Type: Review

References (81)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
2. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
3. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat Med 10 (2004) 789-799
4. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
5. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Genetic alterations during colorectal-tumor development. N Engl J Med 319 (1988) 525-532
6. Bignold L.P., Coghlan B.L., and Jersmann H.P. Hansemann, Boveri, chromosomes and the gametogenesis-related theories of tumours. Cell Biol Int 30 (2006) 640-644
7. Bulow S., Berk T., and Neale K. The history of familial adenomatous polyposis. Fam Cancer 5 (2006) 213-220
8. Gardner E.J. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet 3 (1951) 167-176
9. Lynch H.T. Classics in oncology. Aldred Scott Warthin, M.D., Ph.D. (1866-1931). CA Cancer J Clin 35 (1985) 345-347
10. Lynch H.T., Smyrk T.C., Watson P., et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104 (1993) 1535-1549
11. Umar A., Boland C.R., Terdiman J.P., et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96 (2004) 261-268
12. Morson B. President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med 67 (1974) 451-457
13. Atkin W.S., Morson B.C., and Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 326 (1992) 658-662
14. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329 (1993) 1977-1981
15. Roncucci L., Stamp D., Medline A., et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22 (1991) 287-294
16. Kern S.E. Clonality: more than just a tumor-progression model. J Natl Cancer Inst 85 (1993) 1020-1021
17. Vogelstein B., Fearon E.R., Hamilton S.R., et al. Clonal analysis using recombinant DNA probes from the X-chromosome. Cancer Res 47 (1987) 4806-4813
18. Powell S.M., Zilz N., Beazer-Barclay Y., et al. APC mutations occur early during colorectal tumorigenesis. Nature 359 (1992) 235-237
19. Smith A.J., Stern H.S., Penner M., et al. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54 (1994) 5527-5530
20. Baker S.J., Fearon E.R., Nigro J.M., et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244 (1989) 217-221
21. Fearon E.R., Cho K.R., Nigro J.M., et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247 (1990) 49-56
22. Hahn S.A., Schutte M., Hoque A.T., et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271 (1996) 350-353
23. Eppert K., Scherer S.W., Ozcelik H., et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86 (1996) 543-552
24. McLaughlin-Drubin M.E., and Munger K. Viruses associated with human cancer. Biochim Biophys Acta 1782 (2008) 127-150
25. Bos J.L., Fearon E.R., Hamilton S.R., et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 327 (1987) 293-297
26. Forrester K., Almoguera C., Han K., et al. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327 (1987) 298-303
27. Rajagopalan H., Bardelli A., Lengauer C., et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 418 (2002) 934
28. Morin P.J., Sparks A.B., Korinek V., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
29. Knudson Jr. A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68 (1971) 820-823
30. Vogelstein B., Fearon E.R., Kern S.E., et al. Allelotype of colorectal carcinomas. Science 244 (1989) 207-211
31. Nishisho I., Nakamura Y., Miyoshi Y., et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253 (1991) 665-669
32. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 159-170
33. Kinzler K.W., and Vogelstein B. Landscaping the cancer terrain. Science 280 (1998) 1036-1037
34. Kinzler K.W., Nilbert M.C., Su L.K., et al. Identification of FAP locus genes from chromosome 5q21. Science 253 (1991) 661-665
35. Loeb L.A., Springgate C.F., and Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Res 34 (1974) 2311-2321
36. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51 (1991) 3075-3079
37. Fishel R., Lescoe M.K., Rao M.R., et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75 (1993) 1027-1038
38. Leach F.S., Nicolaides N.C., Papadopoulos N., et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75 (1993) 1215-1225
39. Bronner C.E., Baker S.M., Morrison P.T., et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368 (1994) 258-261
40. Nicolaides N.C., Papadopoulos N., Liu B., et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371 (1994) 75-80
41. Kane M.F., Loda M., Gaida G.M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57 (1997) 808-811
42. Al-Tassan N., Chmiel N.H., Maynard J., et al. Inherited variants of MYH associated with somatic G: C-T: a mutations in colorectal tumors. Nat Genet 30 (2002) 227-232
43. Sieber O.M., Lipton L., Crabtree M., et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348 (2003) 791-799
44. Croitoru M.E., Cleary S.P., Di Nicola N., et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 96 (2004) 1631-1634
45. Hemminki A., Markie D., Tomlinson I., et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391 (1998) 184-187
46. Jenne D.E., Reimann H., Nezu J., et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18 (1998) 38-43
47. Howe J.R., Roth S., Ringold J.C., et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280 (1998) 1086-1088
48. Howe J.R., Bair J.L., Sayed M.G., et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28 (2001) 184-187
49. Marsh D.J., Dahia P.L., Zheng Z., et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16 (1997) 333-334
50. Liaw D., Marsh D.J., Li J., et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16 (1997) 64-67
51. Macleod K. Tumor suppressor genes. Curr Opin Genet Dev 10 (2000) 81-93
52. Boveri T. Zur Frage der Entstehung maligner Tumoren [On the question of the origin of malignant tumors.] (1914), Gustav Fischer Verlag, Jena, Germany [in German]
53. Law D.J., Olschwang S., Monpezat J.P., et al. Concerted nonsyntenic allelic loss in human colorectal carcinoma. Science 241 (1988) 961-965
54. Goelz S.E., Vogelstein B., Hamilton S.R., et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228 (1985) 187-190
55. Greger V., Passarge E., Hopping W., et al. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 83 (1989) 155-158
56. Stoler D.L., Chen N., Basik M., et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A 96 (1999) 15121-15126
57. Wang T.L., Rago C., Silliman N., et al. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci U S A 99 (2002) 3076-3080
58. Ionov Y., Peinado M.A., Malkhosyan S., et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363 (1993) 558-561
59. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260 (1993) 816-819
60. Boland C.R., Thibodeau S.N., Hamilton S.R., et al. National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58 (1998) 5248-5257
61. Goh H.S., and Jass J.R. DNA content and the adenoma-carcinoma sequence in the colorectum. J Clin Pathol 39 (1986) 387-392
62. Luo L., Shen G.Q., Stiffler K.A., et al. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer. Carcinogenesis 27 (2006) 1153-1159
63. Shih I.M., Zhou W., Goodman S.N., et al. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61 (2001) 818-822
64. Cardoso J., Molenaar L., de Menezes R.X., et al. Chromosomal instability in MYH- and APC-mutant adenomatous polyps. Cancer Res 66 (2006) 2514-2519
65. Rajagopalan H., Nowak M.A., Vogelstein B., et al. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3 (2003) 695-701
66. Phear G., Bhattacharyya N.P., and Meuth M. Loss of heterozygosity and base substitution at the APRT locus in mismatch-repair-proficient and -deficient colorectal carcinoma cell lines. Mol Cell Biol 16 (1996) 6516-6523
67. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
68. Wang Z., Cummins J.M., Shen D., et al. Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res 64 (2004) 2998-3001
69. Cahill D.P., Lengauer C., Yu J., et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998) 300-303
70. Michel L.S., Liberal V., Chatterjee A., et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409 (2001) 355-359
71. Bischoff J.R., Anderson L., Zhu Y., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17 (1998) 3052-3065
72. Zhou H., Kuang J., Zhong L., et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20 (1998) 189-193
73. Rajagopalan H., Jallepalli P.V., Rago C., et al. Inactivation of hCDC4 can cause chromosomal instability. Nature 428 (2004) 77-81
74. Akhoondi S., Sun D., von der Lehr N., et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 67 (2007) 9006-9012
75. Pellman D. Cancer. A CINtillating new job for the APC tumor suppressor. Science 291 (2001) 2555-2556
76. Kaplan K.B., Burds A.A., Swedlow J.R., et al. A role for the adenomatous polyposis coli protein in chromosome segregation. Nat Cell Biol 3 (2001) 429-432
77. Fodde R., Kuipers J., Rosenberg C., et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3 (2001) 433-438
78. Teodoridis J.M., Hardie C., and Brown R. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett 268 (2008) 177-186
79. Toyota M., Ahuja N., Ohe-Toyota M., et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96 (1999) 8681-8686
80. Weisenberger D.J., Siegmund K.D., Campan M., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38 (2006) 787-793
81. Ogino S., Kawasaki T., Kirkner G.J., et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9 (2007) 305-314